IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA

Clinical trials for IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA explained in plain language.

Never miss a new study

Get alerted when new IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA trials appear

Sign up with your email to follow new studies for IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Landmark study tracks 1,200 survivors of deadly blood clotting disease

Knowledge-focused Recruiting now

This study aims to understand the long-term health of people who have survived a rare and life-threatening blood clotting disorder called immune thrombotic thrombocytopenic purpura (iTTP). Researchers will look back at the medical records of over 1,200 patients in France to learn…

Matched conditions: IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA

Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:30 UTC

IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA

Get alerted when new IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA trials appear

Landmark study tracks 1,200 survivors of deadly blood clotting disease